NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 1.038
0.00 (0.00%)
Apr 24, 2026, 5:35 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €13.15 million as of April 24, 2026. Its market cap has decreased by -5.64% in one year.
Market Cap
13.15M
Enterprise Value
11.08M
Revenue
188.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.04
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 13.15M, a decrease of -32.45%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 13.15M | -11.88% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | 19.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 35.47M |
| genOway Société anonyme | 23.05M |
| GenSight Biologics | 19.25M |
| Advicenne | 19.18M |
| Aelis Farma | 16.72M |
| Poxel | 14.48M |
| Oncodesign Precision Medicine Société anonyme | 7.97M |
| Plant Advanced Technologies | 7.80M |